FibroBiologics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2022 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
FibroBiologics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2022 to Q2 2025.
  • FibroBiologics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2025 was $2.71M, a 69.2% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2025 $2.71M +$1.11M +69.2% Jun 30, 2025 10-Q 2025-07-31
Q1 2025 $1.29M -$422K -24.7% Mar 31, 2025 10-Q 2025-05-14
Q4 2024 $1.39M -$416K -23% Dec 31, 2024 10-Q 2025-07-31
Q3 2024 $1.5M Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $1.6M Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $1.71M Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $1.81M -$390K -17.7% Dec 31, 2023 10-K 2025-03-31
Q4 2022 $2.2M Dec 31, 2022 10-K 2024-02-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.